Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha)
Shuai Xia(Shanghai Medical College of Fudan University), Yun Zhu(Chinese Academy of Sciences), Fanke Jiao(Fudan University), Zuoling Wen(Chinese Academy of Sciences), Qiaoshuai Lan(Chinese University of Hong Kong), Shibo Jiang(Shanghai Medical College of Fudan University), Lu Lu(Shanghai Medical College of Fudan University), Qian Wang(Shanghai Medical College of Fudan University), Lijue Wang(Fudan University), Fei Sun(University of California, Los Angeles), Linhua Tai(Chinese Academy of Sciences)
Cited by 25
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
|Signal Transduction and Targeted Therapy|2020|363